However, many cancers resist to GEM and the main involved mechanism consists of an up-regulation of the catabolic enzyme Cytidine Deaminase (CDA), deficiency in the anabolism enzyme Deoxycytidine Kinase (DCK), and alterations in nucleoside influx transporters (107). The gene discussed is DCK; the disease is cancer.